Breast Cancer with Brain Metastases
📧 Sign up to get email alerts when something new happens for Breast Cancer with Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases [Phase 2]
Phase 2 trial evaluating cisplatin with or without veliparib in patients with recurrent or metastatic triple-negative or BRCA mutation-assoc…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases [EARLY_Phase 1]
This EARLY_PHASE1 trial evaluating ketoconazole before surgery in patients with recurrent glioma or breast cancer brain metastases was termi…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases [Phase 2]
Phase II trial assessing Dato-DXd in triple-negative breast cancer patients with newly diagnosed or progressing brain metastases is currentl…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis [Phase 2]
A Phase 2 trial is evaluating trastuzumab deruxtecan (T-DXd) with or without neratinib in HER2-positive breast cancer patients with brain me…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis [Phase 2]
Phase 2 clinical trial update on trastuzumab deruxtecan (T-DXd) with or without bevacizumab for HER2-low breast cancer with brain metastases…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases. [Phase 2]
A Phase 2 clinical trial is evaluating SPH4336 in combination with endocrine therapy for breast cancer with brain metastases. The study is c…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases [Phase 2]
A Phase II study is evaluating SHR-A1811 in combination with radiotherapy for breast cancer with brain metastases (HER2-positive and HER2-lo…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis.
A prospective, multicenter observational cohort study is evaluating the efficacy and safety of a novel anti-tumor drug used as a radiosensit…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
A clinical trial evaluated hypofractionated image-guided radiation therapy for patients with stage IV breast cancer. The study status is com…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs [Phase 2]
A Phase 2 trial evaluating Pyrotinib plus Capecitabine for HER2-positive metastatic breast cancer with active brain metastases that have pro…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases [Phase 2]
Phase 2 trial evaluating pyrotinib with capecitabine and bevacizumab for HER2-positive breast cancer with brain metastases; status currently…
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases [Phase 2]
Phase 2 clinical trial update for ARX788 in HER2-positive metastatic breast cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China [Phase 2]
A multi-center Phase 2 trial in China evaluating palbociclib, trastuzumab, pyrotinib, and fulvestrant for ER/PR-positive, HER2-positive brea…
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Proteome-based Immunotherapy of Brain Metastases From Breast Cancer [Phase 2, Phase 3]
ClinicalTrials.gov update on a Phase 2/Phase 3 proteome-based immunotherapy trial for brain metastases from breast cancer; the current trial…
-
CLINICAL_TRIALS withdrawal · 2017-04-21Clinical Trial Update: BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain [Phase 1, Phase 2]
This trial evaluating BBBD followed by methotrexate and carboplatin with or without trastuzumab for breast cancer with brain metastases has …
-
CLINICAL_TRIALS other · 2016-06-07Clinical Trial Update: Expanded Access to ANG1005 for Individual Patients
Expanded access program for ANG1005 (Angiochem) for individual patients with several brain cancers; the program is no longer available.